Published in Med J Aust on September 03, 1990
Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Community Health (1997) 1.28
The new hepatitis virus: hepatitis C virus. Med J Aust (1990) 0.75
Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet (1972) 3.90
Axonal transport of herpes simplex virions to epidermal cells: evidence for a specialized mode of virus transport and assembly. Proc Natl Acad Sci U S A (1994) 3.56
Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology (1988) 3.51
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest (2000) 3.17
Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis (2001) 2.63
Low prevalence of Helicobacter pylori in an Australian duodenal ulcer population: NSAIDitis or the effect of ten years of H. pylori treatment? Aust N Z J Med (1998) 2.46
Hepatitis C virus in intravenous drug users. Med J Aust (1990) 2.33
Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest (1985) 2.28
Anterograde transport of herpes simplex virus type 1 in cultured, dissociated human and rat dorsal root ganglion neurons. J Virol (2000) 2.25
Androgen-induced hepatoma. Lancet (1975) 2.21
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology (1998) 2.19
Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain. Lancet (1973) 2.17
The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C. Med J Aust (1994) 2.15
Darkroom hepatitis after exposure to hydroquinone. Lancet (1995) 2.13
Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis. Nat Genet (1999) 2.06
The management of post-herpetic neuralgia. BMJ (2000) 2.04
HIV gp120 receptors on human dendritic cells. Blood (2001) 2.03
Rotavirus infections of neonates. Lancet (1977) 2.01
Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor. Lancet (1985) 1.96
Anterograde transport of herpes simplex virus proteins in axons of peripheral human fetal neurons: an immunoelectron microscopy study. J Virol (1999) 1.95
Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J Virol Methods (1992) 1.86
CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol (1998) 1.85
Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. J Clin Microbiol (1993) 1.83
Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology (1996) 1.83
Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol (2001) 1.79
Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J Virol (2001) 1.74
Which patients with hepatitis C develop liver complications? Hepatology (2000) 1.73
Variations in CD4 expression by human monocytes and macrophages and their relationships to infection with the human immunodeficiency virus. J Gen Virol (1989) 1.72
Exposure and immunity to hepatitis-B virus in a liver unit. Lancet (1974) 1.68
Consequences of recombination rate variation on quantitative trait locus mapping studies. Simulations based on the Drosophila melanogaster genome. Genetics (2001) 1.64
Dichotomous effects of beta-chemokines on HIV replication in monocytes and monocyte-derived macrophages. J Immunol (1998) 1.54
Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis (2000) 1.51
Nonspecific proctitis: association with human immunodeficiency virus infection in homosexual men. J Infect Dis (1992) 1.51
Adult-to-adult living donor liver transplantation for fulminant hepatic failure. Med J Aust (2001) 1.50
Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis. Br Med J (1975) 1.47
The C-terminal region of the stalk domain of ubiquitous human kinesin heavy chain contains the binding site for kinesin light chain. Biochemistry (1998) 1.47
Diarrhoea--an unrecognised hazard of coeliac plexus block. Aust N Z J Med (1991) 1.44
Pathogenesis of caseous lymphadenitis in sheep and goats. Aust Vet J (1986) 1.44
Genotyping as a diagnostic aid in genetic haemochromatosis. J Gastroenterol Hepatol (1999) 1.43
Antipyrine clearance and response to interferon treatment in patients with chronic active hepatitis C. Hepatology (1995) 1.41
Dementia and pancytopenia in a patient who died of AIDS within one year of primary human immunodeficiency virus infection. Clin Infect Dis (1996) 1.40
Alpha-naphthyl-thiourea-induced pulmonary oedema in the rat: a topographical and electron-microscope study. J Pathol (1972) 1.40
Quality assurance and the Royal Australasian College of Physicians. Aust N Z J Med (1992) 1.39
Outcome, tolerability and compliance of compassionate use interferon and ribavirin for hepatitis C infection in a shared care hospital clinic. Intern Med J (2003) 1.39
Should all pregnant women be screened for hepatitis B surface antigen? Med J Aust (1989) 1.39
Seroprevalence of hepatitis A antibodies among residents of a centre for people with developmental disabilities. Aust N Z J Med (1994) 1.38
Confusion, cortical blindness and fever. Med J Aust (1995) 1.38
gamma Interferon production appears to predict time of recurrence of herpes labialis. J Immunol (1983) 1.32
Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission. J Virol (2001) 1.31
Enhanced drug metabolism in cigarette smokers. Br Med J (1976) 1.31
Cell-mediated immune response in primary biliary cirrhosis to a protein fraction from human bile. Br Med J (1973) 1.30
Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma. J Infect Dis (1996) 1.27
Molecular and catalytic properties of mitochondrial (ketogenic) 3-hydroxy-3-methylglutaryl coenzyme A synthase of liver. J Biol Chem (1975) 1.24
Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies. Immunology (1988) 1.23
In vivo production of cytokines and beta (C-C) chemokines in human recurrent herpes simplex lesions--do herpes simplex virus-infected keratinocytes contribute to their production? J Infect Dis (1998) 1.23
A non-transferrin-bound serum iron in idiopathic hemochromatosis. Dig Dis Sci (1980) 1.23
Leu-3+ T cells produce gamma-interferon in patients with recurrent herpes labialis. J Immunol (1984) 1.23
HIV infection of rectal mucosa. Lancet (1988) 1.22
Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro. J Virol (1999) 1.21
The reliability of serological tests for the diagnosis of genital herpes: a critique. Pathology (1993) 1.20
An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC). J Clin Virol (2001) 1.19
Herbal hepatotoxicity: an expanding but poorly defined problem. J Gastroenterol Hepatol (2000) 1.19
Immunopathology of viral hepatitis in man. Prog Med Virol (1974) 1.19
Differential tropism and chemokine receptor expression of human immunodeficiency virus type 1 in neonatal monocytes, monocyte-derived macrophages, and placental macrophages. J Virol (1998) 1.19
Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology (1995) 1.18
Hepatitis B infection among STD clinic patients in Sydney. Aust N Z J Med (1984) 1.16
Varicella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host. J Virol (2001) 1.15
Rapid diagnosis of acute Epstein-Barr virus infection by an indirect enzyme-linked immunosorbent assay for specific immunoglobulin M (IgM) antibody without rheumatoid factor and specific IgG interference. J Clin Microbiol (1989) 1.14
Unique HIV type 1 V3 region sequences derived from six different regions of brain: region-specific evolution within host-determined quasispecies. AIDS Res Hum Retroviruses (1998) 1.14
Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. J Gen Virol (1998) 1.14
Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis. Immunology (1992) 1.13
Removal of inhibitors of CSF-PCR to improve diagnosis of herpesviral encephalitis. J Virol Methods (1998) 1.13
Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes. Clin Pharmacol Ther (1979) 1.13
Drug-induced cholestasis. Semin Gastrointest Dis (2001) 1.13
HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology (1992) 1.12
Molecular and catalytic properties of cytosolic acetoacetyl coenzyme A thiolase from avian liver. J Biol Chem (1973) 1.11
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice. Br J Cancer (2012) 1.10
3-Hydroxy-3-methylglutaryl coenzyme A synthase. Evidence for an acetyl-S-enzyme intermediate and identification of a cysteinyl sulfhydryl as the site of acetylation. J Biol Chem (1975) 1.10
Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection. J Leukoc Biol (1994) 1.09
Twin studies demonstrate a host cell genetic effect on productive human immunodeficiency virus infection of human monocytes and macrophages in vitro. J Virol (1996) 1.08
Serological diagnosis of infection with human herpesvirus type 6. BMJ (1990) 1.08
Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis. Gut (1977) 1.08
Cell-mediated immunity to hepatitis B surface antigen in blood donors with persistent antigenaemia. Gut (1975) 1.08
Evaluation of rubella immune status by three commercial enzyme-linked immunosorbent assays. J Clin Microbiol (1988) 1.07
Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab (1998) 1.07
Search for persistent enterovirus infection of muscle in inflammatory myopathies. J Neurol Sci (1994) 1.07
Effects of hepatitis G virus coinfection on severity of hepatitis C: relationship to risk factors and response to interferon treatment. J Gastroenterol Hepatol (1998) 1.06
Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats. Biochem Biophys Res Commun (1999) 1.06
Herpes simplex encephalitis in infants. Med J Aust (1986) 1.05
Cytology of synovial effusions in epidemic polyarthritis. Aust N Z J Med (1981) 1.05
Hepatic iron clearance from serum in treated hemochromatosis. Gastroenterology (1978) 1.04
Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution. Liver Transpl (2003) 1.03
Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins. J Virol (1999) 1.03